Brussels, 27/01/2015 (Agence Europe) - The European Medicines Agency (EMA) has recommended suspending the marketing of several hundred generic medicines in Europe, due to the lack of available data. The marketing of these products had been authorised, following positive conclusions in their favour after clinical trials had been carried out by the Indian company, GVK Biosciences, in Hyderabad.
The European Commission suspects that a certain amount of manipulation has occurred and called on...